Skip to content

Effects of rTMS Combined with MCE on Motor Control Ability and Central Responses in Patients with Chronic Low Back Pain

Effects of rTMS Combined with MCE on Motor Control Ability and Central Responses in Patients with Chronic Low Back Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127014
Enrollment
Unknown
Registered
2026-06-23
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Interventions

rTMS Group:rTMS: The treatment was delivered using a repetitive transcranial magnetic stimulation device for a duration of 8 minutes, administered by a therapist trained in rTMS safety and operational
rTMSsham Group:Sham rTMS: In the sham stimulation group, the coil was positioned at a 90-degree angle relative to the scalp, with one wing in contact with the scalp, while all other parameters remaine
rTMS+MCE Group:rTMS combined with Motor Control Exercise: The intervention procedure for this group was consistent with that of the rTMS group. The entire process was performed by a professionally tra
rTMSsham+MCE Group:sham rTMS combined with Motor Control Exercise: This group first received 8 minutes of sham repetitive transcranial magnetic stimulation. The entire procedure was performed by a pro

Sponsors

Chengdu Sport University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. Duration of low back pain >= 3 months; 2. No history of spinal or lower limb surgery or trauma; 3. BMI: 18.5-23.9 kg/m^2; 4. Right-handed general university students aged 18-25 years, not specializing in sports; 5. No contraindications to exercise testing (e.g., severe hypertension, heart disease, peripheral vascular disease, respiratory diseases, etc.); 6. Visual Analog Scale (VAS) score for low back pain >= 3, indicating moderate pain; 7. Oswestry Disability Index (ODI) score > 15%, indicating moderate dysfunction; 8. Positive findings on motor control tests: >= 2 positive items.

Exclusion criteria

Exclusion criteria: 1. Spinal stenosis/fracture, radiculopathy, or history of surgery; 2. Presence of pain in the buttocks and thighs; sensory or reflex abnormalities in the lower limbs; pain in joints other than the lumbar region; 3. Low back pain caused by specific pathological conditions, such as tumors, osteoporosis, lumbar fractures, rheumatoid arthritis, ankylosing spondylitis, lumbar disc herniation with nerve root involvement, spondylolisthesis, etc.; 4. Concurrent severe primary diseases involving the liver, kidneys, hematopoietic system, endocrine system, etc.; 5. Concurrent skin diseases; 6. Pregnant or breastfeeding women, or individuals with psychiatric disorders; 7. Use of medications (e.g., analgesics, nonsteroidal anti-inflammatory drugs, opioid analgesics, etc.) within the three months prior to the experiment; 8. Inability to tolerate the discomfort induced by rTMS (e.g., scalp pain, headache, dental or facial muscle twitching, etc.); 9.Inability to provide accurate information regarding caffeine and nicotine use, or refusal to comply with pre-experiment requirements (to control for potential interference of caffeine and nicotine with fNIRS signals, participants were required to refrain from consuming caffeinated products for at least 6 hours and from smoking for at least 2 hours prior to the experiment).

Design outcomes

Primary

MeasureTime frame
Movement Control Tests;Change in beta values of oxygenated hemoglobin concentration;Pain Intensity;Functional Disability;

Secondary

MeasureTime frame
Hip flexion angle during the supine double leg lowering test;Peak Intra-abdominal Pressure;Surface EMG test root mean square amplitude; Integrated Electromyography;

Countries

China

Contacts

Public ContactZhangYang

Chengdu Sport University

2099511943@qq.com+86 198 2823 5282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026